At week 4, a significant reduction

At week 4, a significant reduction in mean fructosamine levels
from baseline were observed in patients who received metformin
1000 mg/day and bitter melon 2000 mg/day (−16.8 mol/L; 95% CI,
−31.2 to −2.4 and −10.2 mol/L; 95% CI, −19.1 to −1.3, respectively).
In contrast, the 500 and 1000 mg/day of bitter melon groups
did not experience a statistically significant reduction in fructosamine
levels from baseline (by −3.5 mol/L; 95% CI, −11.7 to 4.6
and −10.3 mol/L; 95% CI, −22.7 to 2.2 mol/L, respectively). The
comparison of the mean change of fructosamine levels from baseline
between treatments was not significantly different (p = 0.41)

ผลลัพธ์ (อังกฤษ) 2:

At week 4, a significant Reduction in mean fructosamine levels
were observed in patients from Baseline Who Received metformin
one thousand mg / Day and Bitter Melon two thousandth mg / Day (-16.8 mol / L; 95% CI,
-31.2 to -2.4 and -10.2. mol / L; 95% CI, -19.1 to -1.3, respectively).
In contrast, The 500 and the one thousandth mg / Day of Bitter Melon groups
did Not Experience a statistically significant Reduction in fructosamine
levels from Baseline (by -3.5 mol / L. ; 95% CI, -11.7 to 4.6
and -10.3 mol / L; 95% CI, -22.7 to 2.2 mol / L, respectively). The
comparison of mean The Change from Baseline levels of fructosamine
was between Treatments Not significantly different (P = 0.41).